Phase I trial of ELND 005 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Jan 2010
At a glance
- Drugs ELND 005 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Transition Therapeutics
- 16 Sep 2008 Added Transistion Therapeutics media release.
- 08 Aug 2006 Status change
- 01 May 2006 New trial record.